Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats

We investigated the effect of etoricoxib, a selective cyclooxygenase-2 inhibitor, and indomethacin, a non-selective cyclooxygenase inhibitor, on experimental periodontitis, and compared their gastrointestinal side effects. A ligature was placed around the second upper left molars of female Wistar ra...

Full description

Bibliographic Details
Main Authors: M.C.F. Azoubel, A.M.A. Menezes, D. Bezerra, R.B. Oriá, R.A. Ribeiro, G.A.C. Brito
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2007-01-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2007000100015
_version_ 1811310227496108032
author M.C.F. Azoubel
A.M.A. Menezes
D. Bezerra
R.B. Oriá
R.A. Ribeiro
G.A.C. Brito
author_facet M.C.F. Azoubel
A.M.A. Menezes
D. Bezerra
R.B. Oriá
R.A. Ribeiro
G.A.C. Brito
author_sort M.C.F. Azoubel
collection DOAJ
description We investigated the effect of etoricoxib, a selective cyclooxygenase-2 inhibitor, and indomethacin, a non-selective cyclooxygenase inhibitor, on experimental periodontitis, and compared their gastrointestinal side effects. A ligature was placed around the second upper left molars of female Wistar rats (160 to 200 g). Animals (6 per group) were treated daily with oral doses of 3 or 9 mg/kg etoricoxib, 5 mg/kg indomethacin, or 0.2 mL saline, starting 5 days after the induction of periodontitis, when bone resorption was detected, until the sacrifice on the 11th day. The weight and survival rate were monitored. Alveolar bone loss (ABL) was measured as the sum of distances between the cusp tips and the alveolar bone. The gastric mucosa was examined macroscopically and the periodontium and gastric and intestinal mucosa were examined by histopathology. The ongoing ABL was significantly inhibited (P < 0.05) by 3 and 9 mg/kg etoricoxib and by indomethacin: control = 4.08 ± 0.47 mm; etoricoxib (3 mg/kg) = 1.89 ± 0.26 mm; etoricoxib (9 mg/kg) = 1.02 ± 0.14 mm; indomethacin = 0.64 ± 0.15 mm. Histopathology of periodontium showed that etoricoxib and indomethacin reduced inflammatory cell infiltration, ABL, and cementum and collagen fiber destruction. Macroscopic and histopathological analysis of gastric and intestinal mucosa demonstrated that etoricoxib induces less damage than indomethacin. Animals that received indomethacin presented weight loss starting on the 7th day, and higher mortality rate (58.3%) compared to etoricoxib (0%). Treatment with etoricoxib, even starting when ABL is detected, reduces inflammation and cementum and bone resorption, with fewer gastrointestinal side effects.
first_indexed 2024-04-13T09:54:44Z
format Article
id doaj.art-4e7870a622584fd0bfae62b7c84c1843
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-04-13T09:54:44Z
publishDate 2007-01-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-4e7870a622584fd0bfae62b7c84c18432022-12-22T02:51:27ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2007-01-01401117125Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in ratsM.C.F. AzoubelA.M.A. MenezesD. BezerraR.B. OriáR.A. RibeiroG.A.C. BritoWe investigated the effect of etoricoxib, a selective cyclooxygenase-2 inhibitor, and indomethacin, a non-selective cyclooxygenase inhibitor, on experimental periodontitis, and compared their gastrointestinal side effects. A ligature was placed around the second upper left molars of female Wistar rats (160 to 200 g). Animals (6 per group) were treated daily with oral doses of 3 or 9 mg/kg etoricoxib, 5 mg/kg indomethacin, or 0.2 mL saline, starting 5 days after the induction of periodontitis, when bone resorption was detected, until the sacrifice on the 11th day. The weight and survival rate were monitored. Alveolar bone loss (ABL) was measured as the sum of distances between the cusp tips and the alveolar bone. The gastric mucosa was examined macroscopically and the periodontium and gastric and intestinal mucosa were examined by histopathology. The ongoing ABL was significantly inhibited (P < 0.05) by 3 and 9 mg/kg etoricoxib and by indomethacin: control = 4.08 ± 0.47 mm; etoricoxib (3 mg/kg) = 1.89 ± 0.26 mm; etoricoxib (9 mg/kg) = 1.02 ± 0.14 mm; indomethacin = 0.64 ± 0.15 mm. Histopathology of periodontium showed that etoricoxib and indomethacin reduced inflammatory cell infiltration, ABL, and cementum and collagen fiber destruction. Macroscopic and histopathological analysis of gastric and intestinal mucosa demonstrated that etoricoxib induces less damage than indomethacin. Animals that received indomethacin presented weight loss starting on the 7th day, and higher mortality rate (58.3%) compared to etoricoxib (0%). Treatment with etoricoxib, even starting when ABL is detected, reduces inflammation and cementum and bone resorption, with fewer gastrointestinal side effects.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2007000100015Alveolar bone lossInflammationPeriodontitisCyclooxygenase inhibitorsEtoricoxibIndomethacin
spellingShingle M.C.F. Azoubel
A.M.A. Menezes
D. Bezerra
R.B. Oriá
R.A. Ribeiro
G.A.C. Brito
Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats
Brazilian Journal of Medical and Biological Research
Alveolar bone loss
Inflammation
Periodontitis
Cyclooxygenase inhibitors
Etoricoxib
Indomethacin
title Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats
title_full Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats
title_fullStr Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats
title_full_unstemmed Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats
title_short Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats
title_sort comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats
topic Alveolar bone loss
Inflammation
Periodontitis
Cyclooxygenase inhibitors
Etoricoxib
Indomethacin
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2007000100015
work_keys_str_mv AT mcfazoubel comparisonofetoricoxibandindomethacinforthetreatmentofexperimentalperiodontitisinrats
AT amamenezes comparisonofetoricoxibandindomethacinforthetreatmentofexperimentalperiodontitisinrats
AT dbezerra comparisonofetoricoxibandindomethacinforthetreatmentofexperimentalperiodontitisinrats
AT rboria comparisonofetoricoxibandindomethacinforthetreatmentofexperimentalperiodontitisinrats
AT raribeiro comparisonofetoricoxibandindomethacinforthetreatmentofexperimentalperiodontitisinrats
AT gacbrito comparisonofetoricoxibandindomethacinforthetreatmentofexperimentalperiodontitisinrats